PTPN2 inhibitor (Eilean Therapeutics)

N/A

Report date: 2025/06/11 10:49:00
NME

Base Information

Drug NamePTPN2 inhibitor (Eilean Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein phosphatase non-receptor type 2 inhibitors
TargetsTyrosine-protein phosphatase non-receptor type 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNess Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEilean Therapeutics LLC
Inactive CompaniesNess Therapeutics Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A